Browse the evidence

Obesity has been associated with improved prognosis in patients with established cardiovascular diseases (CVD), particularly coronary heart disease (CHD), heart failure (HF), atrial fibrillation, and pulmonary arterial hypertension.

Clinicians should consider the potential for improved prognosis in obese patients with established CVD when making treatment decisions.

PST receipt was not associated with concurrent and prospective increased self-care behaviors.

Practitioners may need to explore alternative interventions beyond PST to enhance self-care behaviors.

Viscosity seems to have no effect on active CCK and glucagon-like peptide-1.

Practitioners should note that the viscosity of chocolate does not affect CCK or GLP-1 levels.

Future research should standardize economic evaluation methods in SET studies for better comparison across diverse interventions, settings, and populations.

Researchers should aim for consistent evaluation methods to enhance the validity of findings in SET studies.

A single bout of low-intensity cycling with BFR is insufficient to induce intracellular stress responses necessary to activate skeletal muscle autophagy signaling.

Practitioners should note that low-intensity cycling with BFR may not effectively stimulate autophagy in inactive individuals.

No significant findings emerged in White women, African American men, or for the 8-10 week outcomes regarding WCadjBMI or WHRadjBMI.

Results may not be generalizable to all demographic groups, indicating the need for tailored approaches in interventions.

Urinary fructose and sugars intake were not significantly associated.

Practitioners should note that urinary fructose may not reliably indicate dietary fructose intake.

Only 7 studies (9%) had a sample size of more than 50 subjects.

Future studies should aim for larger sample sizes to improve the reliability of findings.

There was no significant effect of ADMP rank on interest in program participation (p = 0.34).

ADMP rank may not be a relevant factor in engaging this population for weight control programs.

A population study on urinary sodium excretion has not been done in Canada.

This indicates a gap in research that may affect public health policy.

Mean total costs per person-year decreased from $5227.25 to $4982.88 over three years.

Cost management strategies may be effective in obesity care over time.

Neither circulating plasma IL-6 nor skeletal muscle IL-6 mRNA are predictors of insulin resistance in patients with type 2 diabetes.

Practitioners should not rely on IL-6 levels as indicators of insulin resistance in type 2 diabetes.

Plasma IL-6 concentrations are higher in type 2 diabetic patients and age-matched non-diabetic controls compared to young healthy subjects.

Higher IL-6 levels in older populations may indicate a need for different health management strategies.

No significant correlations were found between glucose disposal rate (GDR) and plasma IL-6 or skeletal muscle IL-6 mRNA in any group.

GDR is not influenced by IL-6 levels, suggesting other factors may be more relevant for insulin sensitivity.

Obesity has increased from 30.5% during 1999–2000 to 41.9% during 2017–2020.

Health practitioners should be aware of the rising obesity rates when designing interventions.

Diabetic nephropathy affects approximately 700 million people worldwide and is the leading cause of chronic kidney insufficiency.

Healthcare providers should be aware of the high prevalence of diabetic nephropathy in T2D patients.

There is significant societal attention on the issues of overweight and obesity.

Practitioners should be aware of the societal context when addressing obesity in patients.

There was no significant difference in the cost of diabetes therapy between the two groups (p = 0.12).

Practitioners can consider that an open formulary may improve glycemic control without increasing costs.

An intensive lifestyle management program did not reduce clinical cardiovascular outcomes in patients with type 2 diabetes during 10 years of follow-up.

Practitioners should note that intensive lifestyle interventions may not significantly impact cardiovascular outcomes in this population.

Effective nephroprotection requires early identification of at-risk patients through screening.

Implement routine screening for CKD risk factors in clinical practice.

Weight loss in patients with cardiovascular diseases is often associated with increased mortality.

Clinicians should be cautious about recommending weight loss in patients with cardiovascular diseases.

Obesity is now considered a protective factor in risk assessment models for heart failure.

Risk assessment for heart failure should incorporate obesity as a potential protective factor.

More studies are needed to provide conclusive results on the efficacy of eHealth interventions.

Continued research is essential for validating the effectiveness of eHealth interventions.

More studies are needed to provide conclusive results on the efficacy of eHealth interventions.

Future research is essential to validate the effectiveness of eHealth interventions.